Drugs@FDA document
OXACILLIN SODIUM REMS · ANDA 207148 ORIG-1
Drugs@FDA document · WOCKHARDT BIO AG · Nov 2, 2023
Key facts
| Drug name | OXACILLIN SODIUM |
|---|---|
| Document type | REMS |
| Application | ANDA207148 |
| Submission | ORIG-1 |
| Company | WOCKHARDT BIO AG |
| Document date | Nov 2, 2023 |
| FDA document | web.archive.org |
At a glance
- 1–9 Documents for this application
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: